Nifty
Sensex
:
:
22198.35
73095.22
76.30 (0.34%)
305.09 (0.42%)

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 532305 | NSE: INDSWFTLAB

112.15
26-Feb-2024
  • Open
  • High
  • Low
  • Previous Close
  •  111.85
  •  120.10
  •  111.55
  •  112.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  390351
  •  449.98
  •  123.40
  •  53.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 662.07
  • 14.97
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,449.96
  • N/A
  • 1.17

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.00%
  • 7.87%
  • 29.27%
  • FII
  • DII
  • Others
  • 0.31%
  • 0.00%
  • 20.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.26
  • 9.80
  • 10.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.55
  • 12.69
  • 4.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 10.56
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.89
  • 7.76
  • 11.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.84
  • 0.82
  • 0.98

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.66
  • 6.58
  • 5.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
287.51
312.69
-8.05%
289.71
310.21
-6.61%
310.34
280.17
10.77%
304.25
306.65
-0.78%
Expenses
235.82
258.92
-8.92%
224.02
251.46
-10.91%
250.04
227.16
10.07%
239.53
269.95
-11.27%
EBITDA
51.69
53.76
-3.85%
65.70
58.75
11.83%
60.30
53.00
13.77%
64.71
36.69
76.37%
EBIDTM
17.98%
17.19%
22.68%
18.94%
19.43%
18.92%
21.27%
11.97%
Other Income
7.11
8.36
-14.95%
7.40
7.54
-1.86%
5.61
7.39
-24.09%
10.21
21.21
-51.86%
Interest
21.05
22.38
-5.94%
21.14
23.98
-11.84%
20.38
23.98
-15.01%
21.82
23.49
-7.11%
Depreciation
13.56
15.39
-11.89%
13.19
16.41
-19.62%
13.88
16.28
-14.74%
9.29
81.81
-88.64%
PBT
24.19
24.35
-0.66%
38.77
25.91
49.63%
31.64
20.14
57.10%
17.16
-47.40
-
Tax
4.67
-3.27
-
6.93
0.56
1,137.50%
14.24
0.22
6,372.73%
41.17
14.06
192.82%
PAT
19.53
27.62
-29.29%
31.83
25.34
25.61%
17.40
19.92
-12.65%
-24.01
-61.45
-
PATM
6.79%
8.83%
10.99%
8.17%
5.61%
7.11%
-7.89%
-20.04%
EPS
3.29
4.65
-29.25%
5.36
4.29
24.94%
2.92
3.36
-13.10%
-4.08
-10.40
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,191.81
1,207.31
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
660.45
965.08
Net Sales Growth
-1.48%
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
-1.09%
-31.57%
 
Cost Of Goods Sold
627.08
655.59
537.43
451.44
396.66
403.36
390.56
392.19
353.01
407.39
754.92
Gross Profit
564.73
551.73
501.30
439.90
382.98
353.24
371.96
305.24
300.23
253.07
210.16
GP Margin
47.38%
45.70%
48.26%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
38.32%
21.78%
Total Expenditure
949.41
978.11
843.11
708.54
636.16
630.48
628.43
591.47
545.97
571.69
906.18
Power & Fuel Cost
-
76.07
58.45
37.31
34.65
37.44
29.58
26.00
22.65
34.78
36.82
% Of Sales
-
6.30%
5.63%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
5.27%
3.82%
Employee Cost
-
126.17
117.40
97.86
95.92
90.98
88.12
69.65
62.76
50.65
44.95
% Of Sales
-
10.45%
11.30%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
7.67%
4.66%
Manufacturing Exp.
-
43.41
40.85
64.24
59.30
50.06
63.50
43.40
38.56
30.13
26.35
% Of Sales
-
3.60%
3.93%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
4.56%
2.73%
General & Admin Exp.
-
38.17
36.03
27.17
27.58
27.27
28.69
23.33
21.54
20.33
22.37
% Of Sales
-
3.16%
3.47%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
3.08%
2.32%
Selling & Distn. Exp.
-
37.29
39.03
28.74
21.65
21.30
27.92
29.06
28.87
28.33
13.95
% Of Sales
-
3.09%
3.76%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
4.29%
1.45%
Miscellaneous Exp.
-
1.42
13.93
1.77
0.40
0.07
0.06
7.86
18.57
0.09
13.95
% Of Sales
-
0.12%
1.34%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
0.01%
0.71%
EBITDA
242.40
229.20
195.62
182.80
143.48
126.12
134.09
105.95
107.28
88.76
58.90
EBITDA Margin
20.34%
18.98%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
13.44%
6.10%
Other Income
30.33
33.50
43.50
22.71
33.46
36.91
25.82
22.62
15.91
22.25
14.17
Interest
84.39
92.17
95.55
100.22
106.65
92.24
35.38
90.27
106.42
117.29
116.66
Depreciation
49.92
57.36
131.04
87.29
90.06
104.05
86.62
88.26
84.75
84.29
65.77
PBT
111.76
113.17
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
-90.56
-109.35
Tax
67.01
38.69
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
-23.98
-20.05
Tax Rate
59.96%
44.72%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
16.73%
14.11%
PAT
44.75
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
PAT before Minority Interest
44.75
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.75%
3.96%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
-18.07%
-12.64%
PAT Growth
291.51%
-
-
-
-
31.71%
-
-
-
-
 
EPS
7.57
8.09
-0.36
-0.53
-3.59
4.90
3.72
-6.62
-9.93
-20.20
-20.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
681.93
600.97
603.51
640.64
587.81
553.24
531.32
517.43
594.85
725.23
Share Capital
59.81
59.81
59.81
59.81
48.29
46.00
45.46
41.68
41.68
40.96
Total Reserves
622.12
541.17
543.70
580.83
539.53
505.69
483.39
475.74
553.17
674.95
Non-Current Liabilities
741.18
813.57
840.15
828.33
901.32
437.80
494.76
717.24
811.33
983.36
Secured Loans
752.60
847.78
884.13
885.96
953.86
503.97
563.69
666.84
723.03
862.23
Unsecured Loans
0.00
0.00
0.00
4.93
11.72
16.52
28.32
79.48
93.11
102.17
Long Term Provisions
17.79
17.03
15.73
14.76
14.34
13.32
9.16
0.00
0.00
0.00
Current Liabilities
371.09
334.47
314.52
323.07
356.00
935.93
1,005.02
950.81
832.82
630.01
Trade Payables
203.99
175.95
138.82
135.23
126.68
128.64
102.36
132.43
134.11
213.71
Other Current Liabilities
105.67
89.10
81.29
72.92
136.49
490.25
496.93
314.60
248.67
21.50
Short Term Borrowings
49.17
64.03
93.43
114.93
92.52
311.31
405.70
503.66
450.05
390.97
Short Term Provisions
12.25
5.39
0.98
0.00
0.31
5.73
0.03
0.12
0.00
3.83
Total Liabilities
1,794.20
1,748.90
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
2,239.00
2,338.60
Net Block
585.04
627.53
738.65
843.14
901.20
924.59
1,032.56
1,098.73
1,116.82
1,173.77
Gross Block
1,330.92
1,316.68
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
1,404.21
1,405.28
Accumulated Depreciation
745.88
689.15
563.38
516.18
477.75
424.68
374.28
321.78
287.40
231.51
Non Current Assets
629.68
673.56
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
1,319.18
1,349.72
Capital Work in Progress
7.71
10.31
18.84
11.45
19.87
68.60
70.26
78.47
112.83
78.10
Non Current Investment
30.34
29.06
35.53
17.45
31.03
31.02
31.09
17.63
17.52
17.07
Long Term Loans & Adv.
4.17
3.96
6.11
56.95
56.95
63.50
54.24
68.96
72.00
80.78
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
14.31
0.00
0.00
0.00
Current Assets
1,163.12
1,073.32
941.88
863.03
836.09
839.26
828.64
921.70
919.82
988.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
438.60
428.50
375.67
342.82
316.61
316.91
343.56
356.02
348.31
377.03
Sundry Debtors
505.32
454.78
432.39
396.45
350.85
407.76
357.27
372.45
389.04
443.85
Cash & Bank
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
Other Current Assets
201.00
16.92
56.33
38.73
138.66
105.14
111.69
170.66
162.64
147.41
Short Term Loans & Adv.
191.98
151.64
65.90
74.45
96.84
92.09
95.37
157.41
144.03
126.33
Net Current Assets
792.03
738.86
627.36
539.96
480.08
-96.67
-176.37
-29.11
87.01
358.87
Total Assets
1,792.80
1,746.88
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48
2,239.00
2,338.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
194.62
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
98.40
65.53
PBT
113.17
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
-90.57
-109.35
Adjustment
132.78
225.66
179.35
176.02
186.26
103.64
167.95
186.30
169.93
144.59
Changes in Working Capital
-51.33
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
22.87
39.54
Cash after chg. in Working capital
194.62
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
102.23
74.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
-3.83
-9.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.37
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
-35.61
-27.39
Net Fixed Assets
-12.34
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
-34.69
29.24
Net Investments
25.56
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
0.88
0.06
Others
-26.59
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
-1.80
-56.69
Cash from Financing Activity
-185.66
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
-63.72
-37.76
Net Cash Inflow / Outflow
-4.41
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
-0.94
0.38
Opening Cash & Equivalents
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
18.28
Closing Cash & Equivalent
17.07
25.77
11.61
10.58
29.97
9.45
16.13
21.78
19.84
20.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
84.25
68.33
66.35
70.21
73.01
65.58
58.08
56.78
67.21
93.07
ROA
2.70%
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
-5.22%
-5.18%
ROE
10.61%
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
-36.36%
-27.88%
ROCE
13.25%
7.88%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
-1.52%
-1.46%
Fixed Asset Turnover
0.92
0.80
0.67
0.57
0.56
0.56
0.51
0.48
0.48
0.71
Receivable days
144.51
154.46
168.41
174.12
182.19
181.25
185.94
206.44
223.20
158.98
Inventory Days
130.51
140.01
145.99
153.65
152.15
156.48
178.26
190.95
194.38
153.77
Payable days
105.77
106.89
110.78
68.85
63.73
60.79
64.19
12.73
29.95
80.99
Cash Conversion Cycle
169.25
187.58
203.62
258.91
270.60
276.94
300.00
384.67
387.63
231.76
Total Debt/Equity
1.71
2.33
2.56
2.48
3.21
4.38
4.77
6.25
5.12
3.56
Interest Cover
1.94
1.13
1.18
0.81
1.54
2.02
0.39
0.22
-0.22
-0.22

News Update:


  • Ind-Swift Laboratories collaborates with CSIR- IMTECH
    30th Nov 2023, 09:36 AM

    The agreement between Ind-Swift and CSIR-IMTECH will enable scientists from both the organizations to work closely on development of Biotransformation process (Enzymatic Process) for its products

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.